4.5 Article

AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments

Karolina Makowska et al.

Summary: Atopic dermatitis is a chronic inflammatory skin disorder characterized by eczematous lesions and severe itching. It is caused by epidermal barrier defects and immunological imbalances. Recent advancements in understanding the role of interleukins in atopic dermatitis have led to significant breakthroughs in therapy, including monoclonal antibodies and Janus kinase inhibitors. However, some patients do not respond to these treatments, highlighting the complexity of the immunopathogenesis of atopic dermatitis. This review addresses the immunological heterogeneity and presents novel interleukin-oriented therapies for this disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Letter Allergy

Quality of life and mental well-being of adults with atopic dermatitis living in the UK

Gurkiran Birdi et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

Article Dermatology

Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce

Angela L. Bosma et al.

Summary: The TREAT Registry Taskforce is a collaborative network collecting real-world data on atopic eczema patients. This study provides an overview of the eight established TREAT registries and examines the overlap and pooling ability of their datasets. The results show that pooled analyses can be performed on multiple important domain items, enabling future comparative analyses.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Review Dermatology

Factors associated with depression, anxiety and severe mental illness among adults with atopic eczema or psoriasis: a systematic review and meta-analysis

Elizabeth Adesanya et al.

Summary: Evidence suggests a possible association between atopic eczema or psoriasis and mental illness, but the factors associated with mental illness are still unclear. This review identified several factors associated with depression and anxiety among adults with psoriasis, but there is limited research on factors associated with mental illness among adults with atopic eczema or psoriasis.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Article Dermatology

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitis

J. Puelles et al.

Summary: The study assessed the psychometric properties of a single-item self-reported sleep disturbance 11-point numerical rating scale (NRS) in patients with atopic dermatitis, finding it to be reliable, valid, and responsive in evaluating sleep disturbance in these patients.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Review Biochemistry & Molecular Biology

Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes

Ya-Chu Tsai et al.

Summary: Psoriasis and atopic dermatitis are now considered to be a spectrum of disease, with overlapping genetic loci and immunopathogenesis. The clinical presentations also have similarities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Dermatology

Mixed evidence on the relationship between socioeconomic position and dermatitis: A review

Harsimran Bajwa et al.

Summary: The association between socioeconomic position and atopic dermatitis is inconsistent, and it may vary depending on patient and study characteristics. Studies conducted in Europe, among children, and based on self-report of eczema were more likely to find a positive association with socioeconomic position.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Review Allergy

Clinical phenotypes of adult atopic dermatitis and related therapies

Cataldo Patruno et al.

Summary: Atopic dermatitis is a chronic inflammatory skin disease with different clinical phenotypes, and its treatment varies depending on the phenotype. Currently, cyclosporine, alitretinoin, and dupilumab show promising efficacy in treating different phenotypes of atopic dermatitis.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Dermatology

European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy

A. Wollenberg et al.

Summary: The evidence- and consensus-based guideline on atopic eczema, developed according to the EuroGuiDerm Guideline and Consensus Statement Development Manual, involves the participation of 29 experts from 12 European countries. The first part of the guideline provides general information, guidance, and detailed information on systemic treatment options, including conventional immunosuppressive drugs, biologics, and janus kinase inhibitors. The second part will cover other aspects of treatment.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Article Dermatology

Impairment of Quality of Life and Mental Health Status in Adult-Onset Atopic Dermatitis

Juhwan Yoo et al.

Summary: Adult-onset atopic dermatitis patients experience impaired mental health and health-related quality of life compared to normal controls. Dermatologists should consider patients' psychological well-being in addition to clinical symptoms for better treatment outcomes.

ANNALS OF DERMATOLOGY (2022)

Article Allergy

Atopic dermatitis in the pediatric population A cross-sectional, international epidemiologic study

Jonathan Silverberg et al.

Summary: This global survey in 18 countries revealed that atopic dermatitis affects a substantial proportion of the pediatric population, with less than 15% having severe cases. Prevalence and severity varied across countries and age groups, with rural areas generally having lower prevalence than urban or suburban areas.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)

Article Dermatology

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study

C. Patruno et al.

Summary: This study retrospectively observed the efficacy and safety of dupilumab in treating severe atopic dermatitis in patients aged 65 and above. The results indicated that there were no significant differences in efficacy and safety of dupilumab between elderly patients and those aged 18-64, showing good efficacy and safety in treating atopic dermatitis.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Article Dermatology

Childhood atopic dermatitis is associated with a decreased chance of completing education later in life: a register-based cohort study

K. Palsson et al.

Summary: Individuals with mild/moderate or severe atopic dermatitis have a decreased chance of completing education, including basic compulsory education, academic education, vocational education, and master's level education.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Article Dermatology

Association Between Atopic Dermatitis and Educational Attainment in Denmark

Sigrun Alba Johannesdottir Schmidt et al.

Summary: This cohort study in Denmark found an association between hospital-diagnosed AD and reduced educational attainment, although the clinical importance was uncertain due to small absolute differences and possible confounding by familial factors. Future research should explore replicability in other populations and variations by AD phenotype.

JAMA DERMATOLOGY (2021)

Article Dermatology

Association of Atopic Dermatitis Severity With Learning Disability in Children

Joy Wan et al.

Summary: This cross-sectional study found that worse AD severity was associated with greater odds of reported LD, independent of socioeconomic characteristics, AD onset age, and other related disorders. Additional prospective and mechanistic studies are needed to clarify the association of AD with learning difficulties, and it is suggested that children with more severe AD should be screened for learning difficulties to initiate appropriate interventions.

JAMA DERMATOLOGY (2021)

Review Pharmacology & Pharmacy

Nomenclature and clinical phenotypes of atopic dermatitis

Giampiero Girolomoni et al.

Summary: Atopic dermatitis is a heterogeneous disease that resists classification. The review discusses nomenclature and identifies morphologic phenotypes to facilitate proper diagnosis and treatment strategies.Discussion of various morphologic manifestations based on topographic area affected, age, or race is essential for differential diagnosis.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2021)

Article Dermatology

Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany

A. Heratizadeh et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Meeting Abstract Dermatology

Atopic dermatitis in the elderly

S. Williamson et al.

BRITISH JOURNAL OF DERMATOLOGY (2020)

Article Dermatology

Distribution of atopic dermatitis lesions in United States adults

J. Silverberg et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Review Dermatology

Adult-Onset Atopic Dermatitis: Characteristics and Management

Paras P. Vakharia et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)

Review Allergy

Comorbidities and the impact of atopic dermatitis

Jonathan I. Silverberg

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)

Review Health Care Sciences & Services

Review of health economic analyses in atopic dermatitis: how diverse is the literature?

Mandy Gutknecht et al.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2019)

Article Dermatology

Socioeconomic Status and the Prevalence of Skin and Atopic Diseases in Five European Countries

Robert F. Ofenloch et al.

ACTA DERMATO-VENEREOLOGICA (2019)

Review Dermatology

The impact of atopic dermatitis on work life - a systematic review

L. B. Norreslet et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)

Article Dermatology

An assessment of the use of antihistamines in the management of atopic dermatitis

Alice He et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)

Review Allergy

Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?

Thomas Bieber et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Review Allergy

Atopic Dermatitis in Adults: A Diagnostic Challenge

Silvestre J. F. Salvador et al.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2017)

Article Dermatology

Typical and atypical clinical appearance of atopic dermatitis

Nanette B. Silverberg

CLINICS IN DERMATOLOGY (2017)

Review Dermatology

A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standards

Masaki Futamura et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)

Article Dermatology

Adult eczema in Italy: prevalence and associations with environmental factors

G. Pesce et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Article Allergy

The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials

Jochen Schmitt et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)